Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine dose and dosing schedule effects on pupil and accommodation in adults
ACTRN12621000233820Phase 2Not yet recruiting
- Sponsor
- University of New South Wales
- Start
- Mar 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of atropine in myopia (3 arms), sponsored by University of New South Wales. Primary endpoints: Change in initial pupil size and Change in minimum pupil size. Planned start Mar 2021; status: not yet recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on ACTRN12621000233820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000233820.